PCDH10, a novel p53 transcriptional target in regulating cell migration

References

• Aylon Y, Oren M. New plays in the p53 theater. Curr Opin Genet Deve 2011; 21: 86-92; PMID:21317061; http://dx.doi.org/10.1016/j.gde.2010.10.002
   PubMed Web of Science ®Google Scholar
• Bertrand KC, Mack SC, Northcott PA, Garzia L, Dubuc A, Pfister SM et al. PCDH10 is a candidate tumour suppressor gene in medulloblastoma. Child's Nervous System 2011; 27: 1243-9; PMID:21597995; http://dx.doi.org/10.1007/s00381-011-1486-x
   PubMed Web of Science ®Google Scholar
• Fang S, Huang SF, Cao J, Wen YA, Zhang LP, Ren GS. Silencing of PCDH10 in hepatocellular carcinoma via de novo DNA methylation independent of HBV infection or HBX expression. Clin Exp Med 2013; 13: 127-34; PMID:22543497; http://dx.doi.org/10.1007/s10238-012-0182-9
   PubMed Web of Science ®Google Scholar
• Guo F, Zheng Y. Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion. Oncogene 2004; 23: 5577-85; PMID:15122327; http://dx.doi.org/10.1038/sj.onc.1207752
   PubMed Web of Science ®Google Scholar
• Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071-6; PMID:20393566; http://dx.doi.org/10.1038/nature08975
   PubMed Web of Science ®Google Scholar
• Hock AK, Vousden KH. Tumor suppression by p53: fall of the triumvirate? Cell 2012; 149: 1183-5; PMID:22682240; http://dx.doi.org/10.1016/j.cell.2012.05.024
   PubMed Web of Science ®Google Scholar
• Kim SY, Yasuda S, Tanaka H, Yamagata K, Kim H. Non-clustered protocadherin. Cell Adhesion Migration 2011; 5: 97-105; PMID:21173574; http://dx.doi.org/10.4161/cam.5.2.14374
   PubMed Web of Science ®Google Scholar
• Li T, Kon N, Jiang L, Tan M, Ludwig T, Zhao Y, Baer R, Gu W. Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 2012; 149: 1269-83; PMID:22682249; http://dx.doi.org/10.1016/j.cell.2012.04.026
   PubMed Web of Science ®Google Scholar
• Li Y, Yang ZS, Song JJ, Liu Q, Chen JB. Protocadherin-10 is involved in angiogenesis and methylation correlated with multiple myeloma. Int J Mol Med 2012; 29: 704-10; PMID:22245948
   PubMed Web of Science ®Google Scholar
• Li Z, Chim JC, Yang M, Ye J, Wong BC, Qiao L. Role of PCDH10 and its hypermethylation in human gastric cancer. Biochim Biophys Acta 2012; 1823: 298-305; PMID:22206871; http://dx.doi.org/10.1016/j.bbamcr.2011.11.011
   PubMed Web of Science ®Google Scholar
• Lin YL, Li ZG, He ZK, Guan TY, Ma JG. Clinical and prognostic significance of protocadherin-10 (PCDH10) promoter methylation in bladder cancer. J Int Med Res 2012; 40: 2117-23; PMID:23321168; http://dx.doi.org/10.1177/030006051204000609
   PubMed Web of Science ®Google Scholar
• Lin YL, Li ZG, Guan TY. The clinical significance of PCDH10 promoter methylation in patients with bladder transitional cell carcinoma. Urol Int 2013; 90: 219-24; PMID:23171734; http://dx.doi.org/10.1159/000345053
   PubMed Web of Science ®Google Scholar
• Ma JG, He ZK, Ma JH, Li WP, Sun G. Downregulation of protocadherin-10 expression correlates with malignant behaviour and poor prognosis in human bladder cancer. J Int Med Res 2013; 41: 38-47; PMID:23569128; http://dx.doi.org/10.1177/0300060513476989
   PubMed Web of Science ®Google Scholar
• Mak AS. p53 in cell invasion, podosomes, and invadopodia. Cell Adh Migr 2014; 8: 205-214; PMID:24714032; http://dx.doi.org/10.4161/cam.27841
   PubMed Web of Science ®Google Scholar
• Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer 2006; 6: 449-58; PMID:16723991; http://dx.doi.org/10.1038/nrc1886
   PubMed Web of Science ®Google Scholar
• Muller PA, Caswell PT, Doyle B, Iwanicki MP, Tan EH, Karim S, Lukashchuk N, Gillespie DA, Ludwig RL, Gosselin P, et al. Mutant p53 drives invasion by promoting integrin recycling. Cell 2009; 139: 1327-1341; PMID:20064378; http://dx.doi.org/10.1016/j.cell.2009.11.026
   PubMed Web of Science ®Google Scholar
• Muller PA, Vousden KH, Norman JC. p53 and its mutants in tumor cell migration and invasion. J Cell Biol 2011; 192: 209-218; PMID:21263025; http://dx.doi.org/10.1083/jcb.201009059
   PubMed Web of Science ®Google Scholar
• Narayan G, Scotto L, Neelakantan V, Kottoor SH, Wong AH, Loke SL, Mansukhani M, Pothuri B, Wright JD, Kaufmann AM, et al. Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer. Genes, Chromosomes & Cancer 2009; 48: 983-92; http://dx.doi.org/10.1002/gcc.20703
   PubMed Web of Science ®Google Scholar
• Narayan G, Freddy AJ, Xie D, Liyanage H, Clark L, Kisselev S, Un Kang J, Nandula SV, McGuinn C, Subramaniyam S, et al. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance. Genes, Chromosomes Cancer 2011; 50: 1043-53; http://dx.doi.org/10.1002/gcc.20922
   PubMed Web of Science ®Google Scholar
• Narayan G, Xie D, Freddy AJ, Ishdorj G, Do C, Satwani P, Liyanage H, Clark L, Kisselev S, Nandula SV, et al. PCDH10 promoter hypermethylation is frequent in most histologic subtypes of mature lymphoid malignancies and occurs early in lymphomagenesis. Genes, Chromosomes Cancer 2013; 52: 1030-41; http://dx.doi.org/10.1002/gcc.22098
   PubMed Web of Science ®Google Scholar
• Powell E, Piwnica-Worms D, Piwnica-Worms H. Contribution of p53 to metastasis. Cancer Discov 2014; 4: 405-14; PMID:24658082; http://dx.doi.org/10.1158/2159-8290.CD-13-0136
   PubMed Web of Science ®Google Scholar
• Tamura M, Sasaki Y, Koyama R, Takeda K, Idogawa M, Tokino T. Forkhead transcription factor FOXF1 is a novel target gene of the p53 family and regulates cancer cell migration and invasiveness. Oncogene 2014; 33: 4837-46; PMID:24186199; http://dx.doi.org/10.1038/onc.2013.427
   PubMed Web of Science ®Google Scholar
• Tsai NP, Wilkerson JR, Guo W, Maksimova MA, DeMartino GN, Cowan CW, Huber KM. Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95. Cell 2012; 151: 1581-94; PMID:23260144; http://dx.doi.org/10.1016/j.cell.2012.11.040
   PubMed Web of Science ®Google Scholar
• Uemura M, Nakao S, Suzuki ST, Takeichi M, Hirano S. OL-Protocadherin is essential for growth of striatal axons and thalamocortical projections. Nature neuroscience 2007; 10: 1151-9; PMID:17721516; http://dx.doi.org/10.1038/nn1960
   PubMed Web of Science ®Google Scholar
• Wang L, Xie PG, Lin YL, Ma JG, Li WP. Aberrant methylation of PCDH10 predicts worse biochemical recurrence-free survival in patients with prostate cancer after radical prostatectomy. Med Sci Monitor 2014; 20: 1363-8; PMID:25086586; http://dx.doi.org/10.12659/MSM.891241
   PubMed Web of Science ®Google Scholar
• Wang SP, Wang WL, Chang YL, Wu CT, Chao YC, Kao SH, Yuan A, Lin CW, Yang SC, Chan WK, et al. p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat Cell Biol 2009; 11: 694-704; PMID:19448627; http://dx.doi.org/10.1038/ncb1875
   PubMed Web of Science ®Google Scholar
• Xiong S, Tu H, Kollareddy M, Pant V, Li Q, Zhang Y, Jackson JG, Suh YA, Elizondo-Fraire AC, Yang P, et al. Pla2g16 phospholipase mediates gain-of-function activities of mutant p53. Proc Natl Acad Sci U S A 2014; 111: 11145-11150; PMID:25024203; http://dx.doi.org/10.1073/pnas.1404139111
   PubMed Web of Science ®Google Scholar
• Ying J, Li H, Seng TJ, Langford C, Srivastava G, Tsao SW, Putti T, Murray P, Chan AT, Tao Q. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 2006; 25: 1070-80; PMID:16247458; http://dx.doi.org/10.1038/sj.onc.1209154
   PubMed Web of Science ®Google Scholar
• Zhao Y, Yang Y, Trovik J, Sun K, Zhou L, Jiang P, Lau TS, Hoivik EA, Salvesen HB, Sun H, et al. A Novel Wnt regulatory axis in endometrioid endometrial cancer. Cancer Res 2014; 74:5103-17
   PubMed Web of Science ®Google Scholar
• Zhong X, Zhu Y, Mao J, Zhang J, Zheng S. Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer. J Cancer Res Clin Oncol 2013; 139: 485-90; PMID:23180019; http://dx.doi.org/10.1007/s00432-012-1353-5
   PubMed Web of Science ®Google Scholar